Unavailable
Unavailable
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/31/2025 | $30.00 | Buy | BofA Securities |
| 3/31/2025 | $29.00 | Outperform | Wolfe Research |
| 3/31/2025 | $24.00 | Neutral | Goldman |
| 3/31/2025 | $28.00 | Buy | Stifel |
| 3/31/2025 | $28.00 | Overweight | Wells Fargo |
| 3/31/2025 | $27.00 | Overweight | Piper Sandler |
KIRKLAND, Wash., June 05, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (NASDAQ:KMTS), a wearable medical device and digital healthcare company, today announced the appointment of Conor Hanley as an independent director to its board, effective June 4, 2025. "I am delighted to welcome Conor to our board of directors," said Brian Webster, President and CEO of Kestra Medical Technologies. "He brings deep expertise in medical technology and cardiac care and will serve as an invaluable strategic resource as we grow and expand the reach of the ASSURE® system." Mr. Hanley is a chartered director and currently serves as CEO of FIRE1, a venture-backed connected medical device sol
Entrepreneur Of The Year celebrates ambitious entrepreneurs who are shaping the future KIRKLAND, Wash., May 13, 2025 (GLOBE NEWSWIRE) -- Ernst & Young LLP (EY US) announced the finalists for the Entrepreneur Of The Year 2025 Mountain West Award. Now in its 40th year, the Entrepreneur Of The Year program celebrates the bold leaders who disrupt markets through the world's most ground-breaking companies, revolutionizing industries and making a profound impact on communities. The Mountain West program celebrates entrepreneurs from Alaska, Colorado, Idaho, Montana, Oregon, Utah, Washington, and Wyoming. An independent panel of judges selected Brian Webster, President and Chief Executive Offic
KIRKLAND, Wash., April 30, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (NASDAQ:KMTS), a wearable medical device and digital healthcare company, is scheduled to participate in the following upcoming investor conferences: Event: BofA Securities 2025 Health Care ConferenceDate: Wednesday, May 14Presentation time: 6:40 p.m. ET Event: Goldman Sachs 46th Annual Global Healthcare Conference 2025Date: Wednesday, June 11Presentation time: 8:00 a.m. ET Interested parties may access a live webcast and replay of each presentation by visiting the Kestra Medical Technologies investor relations website. About KestraKestra Medical Technologies, Ltd. is a commercial-stage
KIRKLAND, Wash., June 05, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (NASDAQ:KMTS), a wearable medical device and digital healthcare company, today announced the appointment of Conor Hanley as an independent director to its board, effective June 4, 2025. "I am delighted to welcome Conor to our board of directors," said Brian Webster, President and CEO of Kestra Medical Technologies. "He brings deep expertise in medical technology and cardiac care and will serve as an invaluable strategic resource as we grow and expand the reach of the ASSURE® system." Mr. Hanley is a chartered director and currently serves as CEO of FIRE1, a venture-backed connected medical device sol
Nalu Medical, Inc. ("Nalu") announced today the appointment of Raymond W. Cohen to serve as chairman of its board of directors. Raymond Cohen served as the chief executive officer and member of the board of directors of Nasdaq-listed Axonics, Inc., a medical device company he co-founded in 2013 and took public in late October 2018. Axonics ranked No. 1 on the Deloitte Technology Fast 500™ and the Financial Times ranking of the fastest growing companies in the Americas in 2021 and 2022. Cohen retired from Axonics following the November 2024 close of its $3.7 billion sale to Boston Scientific Corporation (NYSE:BSX). Following the sale of Axonics, Cohen was named chairman of the board of Son
BofA Securities initiated coverage of Kestra Medical Technologies with a rating of Buy and set a new price target of $30.00
Wolfe Research initiated coverage of Kestra Medical Technologies with a rating of Outperform and set a new price target of $29.00
Goldman initiated coverage of Kestra Medical Technologies with a rating of Neutral and set a new price target of $24.00
8-K - KESTRA MEDICAL TECHNOLOGIES, LTD. (0001877184) (Filer)
SCHEDULE 13G - KESTRA MEDICAL TECHNOLOGIES, LTD. (0001877184) (Subject)
SCHEDULE 13G - KESTRA MEDICAL TECHNOLOGIES, LTD. (0001877184) (Subject)
KIRKLAND, Wash., April 02, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (NASDAQ:KMTS), a wearable medical device and digital healthcare company, today announced that it will report financial results for the third quarter fiscal 2025 on Monday, April 14. Management will host a corresponding conference call at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time. A live and archived webcast of the conference call will be available in the "Events" section of the investor relations website. Participants are encouraged to register on the website at least 10 minutes prior to the start of the conference call. About KestraKestra Medical Technologies, Ltd. is a commercial-stage wearable